Self-management of Low Molecular Weight Heparin Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Thromboembolism
Interventions
BEHAVIORAL

patient education

"Possible, individualized interventions:~* Improvement of patient's knowledge about medication, therapy and drug application by providing detailed written information material~* Providing a complete equipment package for self-injection (disinfection patches, patches, plasters, waste disposal box for used syringes)~* Patient training: oral instructions for self-injection (and application, if required), exercising the injection technique on a phantom~* First self-injection under control of a specially trained pharmacist"

Trial Locations (2)

CH-4031

University Hospital of Basle, Switzerland, Basel

CH-4101

Kantonsspital Baselland, Switzerland, Bruderholz

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT00794560 - Self-management of Low Molecular Weight Heparin Therapy | Biotech Hunter | Biotech Hunter